People · Operator
Named in public records as an officer, director or promoter · active 2008–2008 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ikaria Holdings Inc | — | Pharmaceuticals | Series C | $54.9M | $1.9B | 2008 |
Michael T. Flaherman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael T. Flaherman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bryan E. Roberts | 1 | 6 |
| DAVID E. SHAW | 1 | 5 |
| Robert T. Nelsen | 1 | 5 |
| Lota S Zoth | 1 | 4 |
| Matthew M. Bennett | 1 | 3 |
| Randy H. Thurman | 1 | 3 |
| MICHAEL R. KENNEDY | 1 | 2 |
| James A. Briggs | 1 | 1 |
| Ralf H. Rosskamp | 1 | 1 |
| Elizabeth A. Larkin | 1 | 1 |
| Csaba M. Szabo | 1 | 1 |
| Alok E. Singh | 1 | 1 |
| Stephen A. Ross | 1 | 1 |
| Daniel E. Tasse | 1 | 1 |
| Aldo E. Belloni | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.